Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 08, 2026 11:00 ET | Source: Intravacc B.V.

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 08, 2026 09:00 ET | Source: Intravacc B.V.

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 08, 2026 08:00 ET | Source: Intravacc B.V.

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 08, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development

Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 08, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc met en avant ses capacités analytiques intégrées destinées à accélérer le développement de vaccins et de produits biologiques

Intravacc propose des méthodes analytiques de pointe pour l’évaluation de l’identification, de la composition, de la pureté, de la structure, de la formulation, de la stabilité et des aspects...
June 08, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc stellt integrierte analytische Kompetenzen zur Beschleunigung der Entwicklung von Impfstoffen und Biologika vor

Intravacc bietet modernste analytische Verfahren zur Bestimmung von Identität, Gehalt, Reinheit, Struktur, Formulierung, Stabilität und für präklinische BewertungenDas Leistungsspektrum umfasst LC-MS,...
May 28, 2026 07:25 ET | Source: Dyadic International, Inc.

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
May 27, 2026 08:00 ET | Source: Intravacc B.V.

Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services.
May 27, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services.
May 27, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc obtient l’agrément CIR en France pour accompagner ses partenariats en R&D vaccinale

Valable pour la période 2025–2027, cet agrément permet aux entreprises innovantes françaises de faire appel à l’expertise d’Intravacc dans le développement de vaccins, le développement analytique et...